|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
letter |
aDepartment of Pathology and
bLaboratory of Molecular Biology, First Department of Obstetrics and Gynecology, General Regional Hospital Papageorgiou, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
Key Words. OCT4 • OCT4 isoform • Differentiation • Polymerase chain reaction • Immunocytochemistry
Correspondence: Vassiliki Kotoula-Dimitriadou, M.D., Department of Pathology, School of Medicine, Aristotle University, University Campus, 54006 Thessaloniki, Greece. Telephone: 30-2310-999-348; Fax: 30-2310-999-229; e-mail: vkotoula{at}auth.gr
Received August 30, 2007;
accepted for publication October 2, 2007.
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLS EXPRESS October 11, 2007.
The transcription factor OCT4 (officially POU5F1; alternatively OCT3, OCT3/4, OTF3, and OTF4) is currently considered a main regulator of human embryonic stem cell pluripotency and self-renewal capacities. Importantly, these stemness properties are attributed to OCT4A, which is one of the two isoforms produced by the OCT4 gene. The second OCT4 isoform, OCT4B, does not share the stemness factor characteristics of OCT4A and is currently considered of unknown function. Hence, when investigating OCT4 expression at the mRNA and protein level, it is important to specify which OCT4 isoform is detected by the applied methods, such as polymerase chain reaction assays and immunocytochemistry antibodies. Here, we discuss the need to distinguish between OCT4A and OCT4B when interpreting OCT4 expression in differentiated cells, such as peripheral blood mononuclear cells.
This article has been cited by other articles:
![]() |
Y. Atlasi, S. J. Mowla, S. A.M. Ziaee, P. J. Gokhale, and P. W. Andrews OCT4 Spliced Variants Are Differentially Expressed in Human Pluripotent and Nonpluripotent Cells Stem Cells, December 1, 2008; 26(12): 3068 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Re and J. L. Cook The physiological basis of intracrine stem cell regulation Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H447 - H453. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Kopp, B. D. Ormsbee, M. Desler, and A. Rizzino Small Increases in the Level of Sox2 Trigger the Differentiation of Mouse Embryonic Stem Cells Stem Cells, April 1, 2008; 26(4): 903 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cantz, G. Key, M. Bleidissel, L. Gentile, D. W. Han, A. Brenne, and H. R. Scholer Absence of OCT4 Expression in Somatic Tumor Cell Lines Stem Cells, March 1, 2008; 26(3): 692 - 697. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
